AFR
Phan also likes ASX-listed regenerative medicine business Avita Medical, which uses a spray formed from patients’ own cells to repair burns victims’ skin, or to treat common disorders such as vitiligo.“After nearly 20 years of development, Avita’s Recell ‘spray-on-skin’ is fast on its way to becoming a component of standard of care in the US,” Phan says. “Under the new CEO, it’s growing revenue strongly, targeted to reach $US100 million within two years, selling into a multibillion-dollar market.”
AFR Phan also likes ASX-listed regenerative medicine business...
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.96 |
Change
0.180(6.47%) |
Mkt cap ! $184.0M | |||
| Open | High | Low | Value | Volume |
| $2.88 | $3.02 | $2.85 | $1.215M | 413.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2499 | $2.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.98 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.98 |
Change
0.180 ( 8.35 %) |
||||
| Open | High | Low | Volume | ||
| $2.88 | $3.01 | $2.88 | 6348 | ||
| Last updated 15.51pm 08/05/2024 ? | |||||
| AVH (ASX) Chart |